We offer our clinical data analytics services to the leading biopharmaceutical companies in the world. Using our bfLEAPTM platform, we enable our clients to predict which patients will respond to a particular therapy in development. Our focus is failed phase 3 drugs.

We use data security protocols designed for highly classified and top level security clearance programs.

Our Process:

  • Meet with you to understand your program and requirements
  • We provide you with our requirements for the data
  • Service Agreement in place
  • The data is transferred to our AI team
  • BF scrubs and analyzes the data using many iterations
  • Our findings are presented to the client
  • Client can then use new information to advance phase 3 program